-
1
-
-
33845222889
-
-
The global eradication of smallpox: final report of the Global Commission for the Certification of Smallpox, Geneva, December 1979. Geneva: World Health Organization; 1980.
-
-
-
-
2
-
-
0003974187
-
-
World Health Organization, Geneva
-
Fenner F., Henderson D.A., Arita I., Jezek Z., and Ladnyi I.D. Smallpox and its eradication (1988), World Health Organization, Geneva
-
(1988)
Smallpox and its eradication
-
-
Fenner, F.1
Henderson, D.A.2
Arita, I.3
Jezek, Z.4
Ladnyi, I.D.5
-
4
-
-
21144439209
-
Adventitious agents and smallpox vaccine in strategic national stockpile
-
Murphy F.A., and Osburn B.I. Adventitious agents and smallpox vaccine in strategic national stockpile. Emerg Infect Dis 11 (2005) 1086-1089
-
(2005)
Emerg Infect Dis
, vol.11
, pp. 1086-1089
-
-
Murphy, F.A.1
Osburn, B.I.2
-
6
-
-
0037385112
-
Smallpox vaccination in 2003: key information for clinicians
-
Bartlett J., Borio L., Radonovich L., Mair J.S., O'Toole T., Mair M., et al. Smallpox vaccination in 2003: key information for clinicians. Clin Infect Dis 36 (2003) 883-902
-
(2003)
Clin Infect Dis
, vol.36
, pp. 883-902
-
-
Bartlett, J.1
Borio, L.2
Radonovich, L.3
Mair, J.S.4
O'Toole, T.5
Mair, M.6
-
7
-
-
0033538314
-
Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
-
Henderson D.A., Inglesby T.V., Bartlett J.G., Ascher M.S., Eitzen E., Jahrling P.B., et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281 (1999) 2127-2137
-
(1999)
JAMA
, vol.281
, pp. 2127-2137
-
-
Henderson, D.A.1
Inglesby, T.V.2
Bartlett, J.G.3
Ascher, M.S.4
Eitzen, E.5
Jahrling, P.B.6
-
8
-
-
0037171711
-
Dose-related effects of smallpox vaccine
-
Frey S.E., Newman F.K., Cruz J., Shelton W.B., Tennant J.M., Polach T., et al. Dose-related effects of smallpox vaccine. N Engl J Med 346 (2002) 1275-1280
-
(2002)
N Engl J Med
, vol.346
, pp. 1275-1280
-
-
Frey, S.E.1
Newman, F.K.2
Cruz, J.3
Shelton, W.B.4
Tennant, J.M.5
Polach, T.6
-
9
-
-
1142273122
-
Dose-dependent neutralizing-antibody responses to vaccinia
-
Belshe R.B., Newman F.K., Frey S.E., Couch R.B., Treanor J.J., Tacket C.O., et al. Dose-dependent neutralizing-antibody responses to vaccinia. J Infect Dis 189 (2004) 493-497
-
(2004)
J Infect Dis
, vol.189
, pp. 493-497
-
-
Belshe, R.B.1
Newman, F.K.2
Frey, S.E.3
Couch, R.B.4
Treanor, J.J.5
Tacket, C.O.6
-
10
-
-
20244380759
-
Clinical responses to undiluted and diluted smallpox vaccine
-
Frey S.E., Couch R.B., Tacket C.O., Treanor J.J., Wolff M., Newman F.K., et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 346 (2002) 1265-1274
-
(2002)
N Engl J Med
, vol.346
, pp. 1265-1274
-
-
Frey, S.E.1
Couch, R.B.2
Tacket, C.O.3
Treanor, J.J.4
Wolff, M.5
Newman, F.K.6
-
11
-
-
24644449093
-
Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial
-
Kim S.H., Yeo S.G., Jang H.C., Park W.B., Lee C.S., Lee K.D., et al. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial. J Infect Dis 192 (2005) 1066-1070
-
(2005)
J Infect Dis
, vol.192
, pp. 1066-1070
-
-
Kim, S.H.1
Yeo, S.G.2
Jang, H.C.3
Park, W.B.4
Lee, C.S.5
Lee, K.D.6
-
12
-
-
28844475184
-
Adverse events associated with smallpox vaccination in the United States, January-October 2003
-
Casey C.G., Iskander J.K., Roper M.H., Mast E.E., Wen X.J., Torok T.J., et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 294 (2005) 2734-2743
-
(2005)
JAMA
, vol.294
, pp. 2734-2743
-
-
Casey, C.G.1
Iskander, J.K.2
Roper, M.H.3
Mast, E.E.4
Wen, X.J.5
Torok, T.J.6
-
13
-
-
0038167809
-
US military smallpox vaccination program experience
-
Grabenstein J.D., and Winkenwerder Jr. W. US military smallpox vaccination program experience. JAMA 289 (2003) 3278-3282
-
(2003)
JAMA
, vol.289
, pp. 3278-3282
-
-
Grabenstein, J.D.1
Winkenwerder Jr., W.2
-
14
-
-
2342440009
-
Smallpox vaccination and myopericarditis: a clinical review
-
Cassimatis D.C., Atwood J.E., Engler R.M., Linz P.E., Grabenstein J.D., and Vernalis M.N. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol 43 (2004) 1503-1510
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 1503-1510
-
-
Cassimatis, D.C.1
Atwood, J.E.2
Engler, R.M.3
Linz, P.E.4
Grabenstein, J.D.5
Vernalis, M.N.6
-
15
-
-
33845197125
-
-
Winkenwerder W Jr. Smallpox vaccination safety summary. Available at: http://www.smallpox.army.mil/event/SPSafetySum.asp. Accessed October 23, 2006.
-
-
-
-
16
-
-
4444307123
-
Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial
-
Talbot T.R., Stapleton J.T., Brady R.C., Winokur P.L., Bernstein D.I., Germanson T., et al. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 292 (2004) 1205-1212
-
(2004)
JAMA
, vol.292
, pp. 1205-1212
-
-
Talbot, T.R.1
Stapleton, J.T.2
Brady, R.C.3
Winokur, P.L.4
Bernstein, D.I.5
Germanson, T.6
-
17
-
-
0242495755
-
Cutting edge: long-term B cell memory in humans after smallpox vaccination
-
Crotty S., Felgner P., Davies H., Glidewell J., Villarreal L., and Ahmed R. Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 (2003) 4969-4973
-
(2003)
J Immunol
, vol.171
, pp. 4969-4973
-
-
Crotty, S.1
Felgner, P.2
Davies, H.3
Glidewell, J.4
Villarreal, L.5
Ahmed, R.6
-
18
-
-
15244351966
-
Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8
-
Kidokoro M., Tashiro M., and Shida H. Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8. Proc Natl Acad Sci U S A 102 (2005) 4152-4157
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 4152-4157
-
-
Kidokoro, M.1
Tashiro, M.2
Shida, H.3
-
19
-
-
33645232533
-
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge
-
Empig C., Kenner J.R., Perret-Gentil M., Youree B.E., Bell E., Chen A., et al. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge. Vaccine 24 (2006) 3686-3694
-
(2006)
Vaccine
, vol.24
, pp. 3686-3694
-
-
Empig, C.1
Kenner, J.R.2
Perret-Gentil, M.3
Youree, B.E.4
Bell, E.5
Chen, A.6
-
20
-
-
13144283663
-
Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial
-
Greenberg R.N., Kennedy J.S., Clanton D.J., Plummer E.A., Hague L., Cruz J., et al. Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial. Lancet 365 (2005) 398-409
-
(2005)
Lancet
, vol.365
, pp. 398-409
-
-
Greenberg, R.N.1
Kennedy, J.S.2
Clanton, D.J.3
Plummer, E.A.4
Hague, L.5
Cruz, J.6
-
21
-
-
7444242665
-
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain): a second-generation smallpox vaccine for biological defense
-
Monath T.P., Caldwell J.R., Mundt W., Fusco J., Johnson C.S., Buller M., et al. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain): a second-generation smallpox vaccine for biological defense. Int J Infect Dis 8 suppl 2 (2004) S31-S44
-
(2004)
Int J Infect Dis
, vol.8
, Issue.SUPPL. 2
-
-
Monath, T.P.1
Caldwell, J.R.2
Mundt, W.3
Fusco, J.4
Johnson, C.S.5
Buller, M.6
-
22
-
-
0141573164
-
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine
-
Weltzin R., Liu J., Pugachev K.V., Myers G.A., Coughlin B., Blum P.S., et al. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med 9 (2003) 1125-1130
-
(2003)
Nat Med
, vol.9
, pp. 1125-1130
-
-
Weltzin, R.1
Liu, J.2
Pugachev, K.V.3
Myers, G.A.4
Coughlin, B.5
Blum, P.S.6
-
23
-
-
2942693560
-
Modified vaccinia Ankara: potential as an alternative smallpox vaccine
-
McCurdy L.H., Larkin B.D., Martin J.E., and Graham B.S. Modified vaccinia Ankara: potential as an alternative smallpox vaccine. Clin Infect Dis 38 (2004) 1749-1753
-
(2004)
Clin Infect Dis
, vol.38
, pp. 1749-1753
-
-
McCurdy, L.H.1
Larkin, B.D.2
Martin, J.E.3
Graham, B.S.4
-
24
-
-
0016400312
-
[MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's translation)]
-
Stickl H., Hochstein-Mintzel V., Mayr A., Huber H.C., Schafer H., and Holzner A. [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's translation)]. Dtsch Med Wochenschr 99 (1974) 2386-2392
-
(1974)
Dtsch Med Wochenschr
, vol.99
, pp. 2386-2392
-
-
Stickl, H.1
Hochstein-Mintzel, V.2
Mayr, A.3
Huber, H.C.4
Schafer, H.5
Holzner, A.6
-
25
-
-
12144290086
-
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
-
Earl P.L., Americo J.L., Wyatt L.S., Eller L.A., Whitbeck J.C., Cohen G.H., et al. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature 428 (2004) 182-185
-
(2004)
Nature
, vol.428
, pp. 182-185
-
-
Earl, P.L.1
Americo, J.L.2
Wyatt, L.S.3
Eller, L.A.4
Whitbeck, J.C.5
Cohen, G.H.6
-
26
-
-
23844526887
-
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model
-
Meseda C.A., Garcia A.D., Kumar A., Mayer A.E., Manischewitz J., King L.R., et al. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model. Virology 339 (2005) 164-175
-
(2005)
Virology
, vol.339
, pp. 164-175
-
-
Meseda, C.A.1
Garcia, A.D.2
Kumar, A.3
Mayer, A.E.4
Manischewitz, J.5
King, L.R.6
-
27
-
-
7644238902
-
Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4
-
McCurdy L.H., Rutigliano J.A., Johnson T.R., Chen M., and Graham B.S. Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4. J Virol 78 (2004) 12471-12479
-
(2004)
J Virol
, vol.78
, pp. 12471-12479
-
-
McCurdy, L.H.1
Rutigliano, J.A.2
Johnson, T.R.3
Chen, M.4
Graham, B.S.5
-
28
-
-
32844466244
-
Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
-
Vollmar J., Arndtz N., Eckl K.M., Thomsen T., Petzold B., Mateo L., et al. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine. Vaccine 24 (2006) 2065-2070
-
(2006)
Vaccine
, vol.24
, pp. 2065-2070
-
-
Vollmar, J.1
Arndtz, N.2
Eckl, K.M.3
Thomsen, T.4
Petzold, B.5
Mateo, L.6
-
29
-
-
1842532903
-
Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge
-
Wyatt L.S., Earl P.L., Eller L.A., and Moss B. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge. Proc Natl Acad Sci U S A 101 (2004) 4590-4595
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 4590-4595
-
-
Wyatt, L.S.1
Earl, P.L.2
Eller, L.A.3
Moss, B.4
-
30
-
-
19944430572
-
Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge
-
Edghill-Smith Y., Bray M., Whitehouse C.A., Miller D., Mucker E., Manischewitz J., et al. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. J Infect Dis 191 (2005) 372-381
-
(2005)
J Infect Dis
, vol.191
, pp. 372-381
-
-
Edghill-Smith, Y.1
Bray, M.2
Whitehouse, C.A.3
Miller, D.4
Mucker, E.5
Manischewitz, J.6
-
31
-
-
0036310570
-
Immunogenicity and safety of defective vaccinia virus Lister: comparison with modified vaccinia virus Ankara
-
Ober B.T., Bruhl P., Schmidt M., Wieser V., Gritschenberger W., Coulibaly S., et al. Immunogenicity and safety of defective vaccinia virus Lister: comparison with modified vaccinia virus Ankara. J Virol 76 (2002) 7713-7723
-
(2002)
J Virol
, vol.76
, pp. 7713-7723
-
-
Ober, B.T.1
Bruhl, P.2
Schmidt, M.3
Wieser, V.4
Gritschenberger, W.5
Coulibaly, S.6
-
32
-
-
3142527261
-
Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox
-
Hooper J.W., Thompson E., Wilhelmsen C., Zimmerman M., Ichou M.A., Steffen S.E., et al. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol 78 (2004) 4433-4443
-
(2004)
J Virol
, vol.78
, pp. 4433-4443
-
-
Hooper, J.W.1
Thompson, E.2
Wilhelmsen, C.3
Zimmerman, M.4
Ichou, M.A.5
Steffen, S.E.6
-
33
-
-
33747149959
-
Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy
-
Otero M., Calarota S.A., Dai A., De Groot A.S., Boyer J.D., and Weiner D.B. Efficacy of novel plasmid DNA encoding vaccinia antigens in improving current smallpox vaccination strategy. Vaccine 24 (2006) 4461-4470
-
(2006)
Vaccine
, vol.24
, pp. 4461-4470
-
-
Otero, M.1
Calarota, S.A.2
Dai, A.3
De Groot, A.S.4
Boyer, J.D.5
Weiner, D.B.6
-
34
-
-
4544371098
-
Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions
-
Fogg C., Lustig S., Whitbeck J.C., Eisenberg R.J., Cohen G.H., and Moss B. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. J Virol 78 (2004) 10230-10237
-
(2004)
J Virol
, vol.78
, pp. 10230-10237
-
-
Fogg, C.1
Lustig, S.2
Whitbeck, J.C.3
Eisenberg, R.J.4
Cohen, G.H.5
Moss, B.6
-
35
-
-
0037205534
-
-
21 CFR Parts 314 and 601. Federal Register May 31, 2002;67(105):37988-98.
-
-
-
-
36
-
-
23944512221
-
Virulence differences between monkeypox virus isolates from West Africa and the Congo basin
-
Chen N., Li G., Liszewski M.K., Atkinson J.P., Jahrling P.B., Feng Z., et al. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology 340 (2005) 46-63
-
(2005)
Virology
, vol.340
, pp. 46-63
-
-
Chen, N.1
Li, G.2
Liszewski, M.K.3
Atkinson, J.P.4
Jahrling, P.B.5
Feng, Z.6
-
37
-
-
26244436841
-
A tale of two clades: monkeypox viruses
-
Likos A.M., Sammons S.A., Olson V.A., Frace A.M., Li Y., Olsen-Rasmussen M., et al. A tale of two clades: monkeypox viruses. J Gen Virol 86 (2005) 2661-2672
-
(2005)
J Gen Virol
, vol.86
, pp. 2661-2672
-
-
Likos, A.M.1
Sammons, S.A.2
Olson, V.A.3
Frace, A.M.4
Li, Y.5
Olsen-Rasmussen, M.6
-
38
-
-
33845211430
-
-
8th reports of the International Committee on Taxonomy of viruses. Available at: http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/index.htm. Accessed October 23, 2006.
-
-
-
-
39
-
-
33845229082
-
-
Smallpox vaccine dried, calf lymph type. Available at: http://www.fda.gov/CBER/label/smalwye070303LB.pdf. Accessed October 23, 2006.
-
-
-
-
40
-
-
33845204121
-
-
® challenge in vaccinia-naive and vaccinia-immune individuals. Vaccine 2006. In press.
-
-
-
|